MCID: FML010
MIFTS: 63

Familial Medullary Thyroid Carcinoma malady

Genetic diseases, Cancer diseases, Rare diseases, Gastrointestinal diseases, Endocrine diseases categories
Download this MalaCard

Summaries for Familial Medullary Thyroid Carcinoma

About this section
Sources:
65Wikipedia, 47OMIM, 33MalaCards
See all sources

Fully expand this MalaCard
Wikipedia:65 The term multiple endocrine neoplasia (MEN) encompasses several distinct syndromes featuring tumors of... more...

MalaCards: Familial Medullary Thyroid Carcinoma, also known as thyroid carcinoma, familial medullary, is related to multiple endocrine neoplasia and multiple endocrine neoplasia type 2a. An important gene associated with Familial Medullary Thyroid Carcinoma is NTRK1 (neurotrophic tyrosine kinase, receptor, type 1), and among its related pathways are EGF receptor (ErbB1) signaling pathway and Growth hormone receptor signaling. The compounds cipa and mibg have been mentioned in the context of this disorder. Affiliated tissues include thyroid and testes, and related mouse phenotypes are muscle and endocrine/exocrine gland.

Description from OMIM:47 155240

Aliases & Classifications for Familial Medullary Thyroid Carcinoma

About this section
Sources:
8Disease Ontology, 10DISEASES, 20GeneTests, 22GTR, 45Novoseek, 62UMLS, 47OMIM
See all sources

Classifications:



Aliases & Descriptions:

familial medullary thyroid carcinoma 8 10
thyroid carcinoma, familial medullary 8 20 22 45 62
medullary thyroid carcinoma, familial 47


External Ids:

Disease Ontology8 DOID:0050547
OMIM47 155240

Related Diseases for Familial Medullary Thyroid Carcinoma

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Thyroid Medullary Carcinoma family:

familial medullary thyroid carcinoma Ntrk1-Related Familial Medullary Thyroid Carcinoma

Diseases related to Familial Medullary Thyroid Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 86)
idRelated DiseaseScoreTop Affiliating Genes
1multiple endocrine neoplasia31.3SDHD, SDHB, RET, SDHC, CALCA, GDNF
2multiple endocrine neoplasia type 2a31.2SDHB, CALCA, RET, SDHC, SDHD, GDNF
3hirschsprung's disease30.9RET, GDNF
4pheochromocytoma30.9SDHB, SDHD, RET
5papillary thyroid carcinoma30.6RET, NTRK1, STAT3
6phaeochromocytoma30.6SDHB, RET, SDHC, SDHD, CALCA
7parathyroid adenoma30.5CALCA, RET
8thyroid medullary carcinoma30.4RET, NTRK1, CALCA, GDNF
9adenoma30.3RET, GDNF, MAPK3, CALCA, NTRK1
10thyroiditis11.2
11amyloidosis10.5
12ntrk1-related familial medullary thyroid carcinoma10.4
13lichen amyloidosis10.4
14sipple syndrome10.2
15cowden disease10.1RET
16central hypoventilation syndrome10.1GDNF
17pancreatic islet cell tumors10.1CALCA, RET
18autosomal dominant disease10.1RET, CALCA
19nodular goiter10.1RET, CALCA
20paragangliomas 110.1RET, SDHB
21renal dysplasia10.1RET, GDNF
22follicular thyroid carcinoma10.1RET, CALCA
23hypoparathyroidism10.1CALCA, RET
24primary hyperparathyroidism10.1CALCA, RET
25intestinal obstruction10.1GDNF, RET
26hypothyroidism10.1RET, CALCA
27renal agenesis10.1GDNF, RET
28neurofibromatosis10.1SDHD, SDHB
29thyroid cancer, anaplastic10.1RET, CALCA
30glomus tumor10.1SDHD, SDHB
31goiter10.1CALCA, RET
32diabetic neuropathy10.1NTRK1, GDNF
33ganglioneuroma10.1NTRK1, RET
34neuroma10.1GDNF, RET, CALCA
35carcinoid syndrome10.1CALCA, SDHD, RET
36familial colorectal cancer10.0RET, SDHD, SDHB
37brain ischemia10.0GDNF, MAPK3
38autoimmune thyroiditis10.0CALCA, RET
39cushing's syndrome10.0CALCA, RET
40follicular adenoma10.0RET, NTRK1, CALCA
41papillary carcinoma10.0CALCA, NTRK1, RET
42thyroid cancer10.0NTRK1, RET, CALCA
43hereditary paraganglioma-pheochromocytoma syndromes10.0SDHD, SDHC, SDHB
44paraganglioma and gastric stromal sarcoma10.0SDHB, SDHD, SDHC
45carotid body tumor10.0SDHC, SDHB, SDHD
46carney triad10.0SDHB, SDHD, SDHC
47chondroma10.0SDHD, SDHC, SDHB
48adrenal adenoma10.0SDHB, SDHC, SDHD
49glaucoma10.0RET, NTRK1, GDNF
50pain agnosia10.0FOS, CALCA

Graphical network of the top 20 diseases related to Familial Medullary Thyroid Carcinoma:



Diseases related to familial medullary thyroid carcinoma

Symptoms for Familial Medullary Thyroid Carcinoma

About this section
Sources:
47OMIM
See all sources

Symptoms by clinical synopsis from OMIM:

155240

Clinical features from OMIM:

155240

Drugs & Therapeutics for Familial Medullary Thyroid Carcinoma

About this section
Sources:
42NIH Clinical Center, 6ClinicalTrials, 62UMLS, 41NDF-RT
See all sources

Drug clinical trials:

Search ClinicalTrials for Familial Medullary Thyroid Carcinoma

Search NIH Clinical Center for Familial Medullary Thyroid Carcinoma

Genetic Tests for Familial Medullary Thyroid Carcinoma

About this section
Sources:
20GeneTests, 22GTR
See all sources

Genetic tests related to Familial Medullary Thyroid Carcinoma:

id Genetic test Affiliating Genes
1 Familial Medullary Thyroid Carcinoma20 22

Anatomical Context for Familial Medullary Thyroid Carcinoma

About this section
Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Familial Medullary Thyroid Carcinoma:

33
Thyroid, Testes

Animal Models for Familial Medullary Thyroid Carcinoma or affiliated genes

About this section
Sources:
37MGI
See all sources

MGI Mouse Phenotypes related to Familial Medullary Thyroid Carcinoma:

37 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.5MAPK3, NTRK1, GDNF, STAT3, RET
2MP:00053798.1SDHD, STAT3, RET, FOS, GDNF
3MP:00053858.1CALCA, MAPK3, STAT3, GDNF, SDHD, RET
4MP:00028738.0SDHD, STAT3, FOS, NTRK1, CALCA, RET
5MP:00107717.9STAT3, NTRK1, FOS, MAPK3, CALCA
6MP:00053807.8SDHD, STAT3, FOS, CALCA, RET
7MP:00020067.7RET, STAT3, FOS, SDHD, MAPK3, CALCA
8MP:00053977.6NTRK1, RET, FOS, MAPK3, GDNF, STAT3
9MP:00053877.6GDNF, RET, STAT3, NTRK1, MAPK3, FOS
10MP:00053767.5FOS, STAT3, RET, CALCA, MAPK3, SDHD
11MP:00053787.3GDNF, NTRK1, FOS, STAT3, RET, SDHD
12MP:00053847.3MAPK3, FOS, STAT3, SDHD, GDNF, RET
13MP:00053867.0GDNF, SDHD, RET, STAT3, NTRK1, MAPK3
14MP:00036317.0STAT3, GDNF, SDHD, FOS, RET, NTRK1
15MP:00107686.5CALCA, GDNF, SDHD, SDHC, RET, STAT3

Publications for Familial Medullary Thyroid Carcinoma

About this section
Sources:
52PubMed
See all sources

Articles related to Familial Medullary Thyroid Carcinoma:

(show top 50)    (show all 99)
idTitleAuthorsYear
1
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma. (21688339)
2012
2
Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma. (22068382)
2012
3
New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. (18771606)
2009
4
Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis. (19445625)
2009
5
Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease. (17208566)
2007
6
Clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinoma. (16384843)
2006
7
A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. (16649977)
2006
8
An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma. (16954442)
2006
9
A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease. (15991157)
2005
10
Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg. (16419493)
2005
11
No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma. (16322339)
2005
12
RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. (15271413)
2004
13
Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634. (15517481)
2004
14
A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. (14602786)
2003
15
Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers]. (12673960)
2003
16
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations? (14668737)
2003
17
A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule. (12072055)
2002
18
Familial medullary thyroid carcinoma (FMTC). Study of one family (treatment criteria). (11289752)
2001
19
Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. (11524247)
2001
20
Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET. (11732489)
2001
21
Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy. (11331212)
2001
22
Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease. (10474127)
1999
23
Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. (10445857)
1999
24
Prognosis of a family with familial medullary thyroid carcinoma. (10464711)
1999
25
Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation. (10076727)
1999
26
A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma. (9452077)
1998
27
Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. (9436479)
1997
28
Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. (9230192)
1997
29
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. (8981969)
1997
30
A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation. (9263528)
1997
31
Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting. (9259198)
1997
32
Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family. (9003111)
1996
33
Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma. (8954146)
1996
34
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. (8600671)
1995
35
Multiple endocrine neoplasia type 2A, type 2B and familial medullary thyroid carcinoma syndrome]. (8538031)
1995
36
A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. (7835899)
1994
37
Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis. (7913024)
1994
38
Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. (1672289)
1991
39
Incidence of sporadic and familial medullary thyroid carcinoma in Sweden 1959 through 1981. A nationwide study in 126 patients. Swedish MCT Study Group. (2310607)
1990
40
Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981. (2563669)
1989
41
Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. (3697657)
1986
42
Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma. (2870690)
1985
43
Screening for familial medullary thyroid carcinoma: a review. (6747984)
1984
44
Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. (7061688)
1982
45
Familial medullary thyroid carcinoma and C cell hyperplasia. (7285384)
1981
46
Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. (692625)
1978
47
Cellular immune responses in familial medullary thyroid carcinoma. (321956)
1977
48
Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report. (1224435)
1975
49
Familial medullary thyroid carcinoma and pheochromocytoma: epidemiologic investigations. (4359415)
1974
50
Studies in familial (medullary) thyroid carcinoma. (4347303)
1972

Variations for Familial Medullary Thyroid Carcinoma

About this section
Sources:
64UniProtKB/Swiss-Prot, 1 National Center for Biotechnology Information (Clinvar), 7dbSNP
See all sources

UniProtKB/Swiss-Prot genetic disease variations for Familial Medullary Thyroid Carcinoma:

64 (show all 30)
id Symbol AA change Variation ID SNP ID
1RETp.Cys609TyrVAR_006306rs77939446
2RETp.Cys611TrpVAR_006308rs80069458
3RETp.Cys618ArgVAR_006311rs76262710
4RETp.Cys618PheVAR_006312
5RETp.Cys618SerVAR_006313rs79781594
6RETp.Cys618TyrVAR_006314
7RETp.Cys620GlyVAR_006315
8RETp.Cys620ArgVAR_006316
9RETp.Cys620SerVAR_006317
10RETp.Cys620PheVAR_006318rs77503355
11RETp.Cys630PheVAR_006320
12RETp.Cys634TyrVAR_006325
13RETp.Cys634ArgVAR_006326
14RETp.Cys634SerVAR_006327
15RETp.Cys634TrpVAR_006328
16RETp.Glu768AspVAR_006335rs78014899
17RETp.Val804LeuVAR_006336rs79658334
18RETp.Val804MetVAR_006337rs79658334
19RETp.Met918ThrVAR_006342rs74799832
20RETp.Thr946MetVAR_006345
21RETp.Cys611GlyVAR_009472
22RETp.Cys630SerVAR_009477
23RETp.Cys630TyrVAR_009478
24RETp.Leu790PheVAR_009482rs75030001
25RETp.Tyr791PheVAR_009483rs77724903
26RETp.Ser891AlaVAR_009486rs75234356
27RETp.Arg844LeuVAR_011582rs55947360
28RETp.Ala639GlyVAR_012743
29RETp.Ala641GlyVAR_012744
30RETp.Ser922PheVAR_012745

Clinvar genetic disease variations for Familial Medullary Thyroid Carcinoma:

1 (show all 17)
id Gene Name Type Significance SNP ID Assembly Location
1NTRK1NM_001007792.1(NTRK1): c.1730G> T (p.Gly577Val)single nucleotide variantBenign, Pathogenicrs6339GRCh37Chr 1, 156848946: 156848946
2NTRK1NM_001007792.1(NTRK1): c.1730G> T (p.Gly577Val)single nucleotide variantBenign, Pathogenicrs6339GRCh37Chr 1, 156848946: 156848946
3RETNM_020975.4(RET): c.1901G> T (p.Cys634Phe)single nucleotide variantPathogenicrs75996173GRCh37Chr 10, 43609949: 43609949
4RETNM_020975.4(RET): c.1853G> C (p.Cys618Ser)single nucleotide variantPathogenicrs79781594GRCh37Chr 10, 43609097: 43609097
5RETNM_020975.4(RET): c.1852T> C (p.Cys618Arg)single nucleotide variantPathogenicrs76262710GRCh37Chr 10, 43609096: 43609096
6RETNM_020975.4(RET): c.2304G> C (p.Glu768Asp)single nucleotide variantPathogenicrs78014899GRCh37Chr 10, 43613840: 43613840
7RETNM_020975.4(RET): c.2370G> C (p.Leu790Phe)single nucleotide variantPathogenicrs75030001GRCh37Chr 10, 43613906: 43613906
8RETNM_020975.4(RET): c.2372A> T (p.Tyr791Phe)single nucleotide variantBenign, Likely benign, Pathogenicrs77724903GRCh37Chr 10, 43613908: 43613908
9RETRET, 9-BP DUP, EX8duplicationPathogenic
10RETNM_020975.4(RET): c.1859G> C (p.Cys620Ser)single nucleotide variantPathogenicrs77503355GRCh37Chr 10, 43609103: 43609103
11RETNM_020975.4(RET): c.1825T> C (p.Cys609Arg)single nucleotide variantPathogenicrs77558292GRCh37Chr 10, 43609069: 43609069
12RETNM_020975.4(RET): c.2410G> T (p.Val804Leu)single nucleotide variantPathogenicrs79658334GRCh37Chr 10, 43614996: 43614996
13RETNM_020975.4(RET): c.1597G> T (p.Gly533Cys)single nucleotide variantPathogenicrs75873440GRCh37Chr 10, 43607621: 43607621
14RETNM_020975.4(RET): c.2671T> G (p.Ser891Ala)single nucleotide variantPathogenicrs75234356GRCh37Chr 10, 43615592: 43615592
15RETNM_020975.4(RET): c.1585_1593dupGAGGAGTGT (p.Cys531_Gly532insGluGluCys)duplicationPathogenicrs377767434GRCh37Chr 10, 43607609: 43607617
16RETNM_020975.4(RET): c.2735G> C (p.Arg912Pro)single nucleotide variantPathogenicrs78347871GRCh37Chr 10, 43617398: 43617398
17NTRK1NM_001007792.1(NTRK1): c.1702C> T (p.His568Tyr)single nucleotide variantBenign, Pathogenicrs6336GRCh37Chr 1, 156848918: 156848918

Expression for genes affiliated with Familial Medullary Thyroid Carcinoma

About this section
Sources:
2BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Familial Medullary Thyroid Carcinoma

Search GEO for disease gene expression data for Familial Medullary Thyroid Carcinoma.

Pathways for genes affiliated with Familial Medullary Thyroid Carcinoma

About this section
Sources:
50PathCards, 38NCBI BioSystems Database, 55Reactome, 30KEGG, 51PharmGKB, 60Thomson Reuters, 53QIAGEN, 57SinoBiological, 54R&D Systems, 61Tocris Bioscience
See all sources

Pathways related to Familial Medullary Thyroid Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 77)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.3STAT3, MAPK3
29.3MAPK3, STAT3
39.2MAPK3, RET, NTRK1
49.1FOS, STAT3
5
Show member pathways
TCA cycle38
pyruvate decarboxylation to acetyl CoA38
NAD phosphorylation and dephosphorylation38
TCA Cycle38
conversion of glucose to acetyl CoA and entry into the TCA cycle38
9.1SDHC, SDHD, SDHB
6
Show member pathways
L-serine degradation38
pentose phosphate pathway (oxidative branch)38
formaldehyde oxidation II (glutathione-dependent)38
9.1SDHB, SDHD, SDHC
79.1MAPK3, RET, GDNF
89.0MAPK3, FOS
99.0MAPK3, FOS
109.0MAPK3, FOS
119.0FOS, MAPK3
12
Show member pathways
9.0NTRK1, STAT3, MAPK3
13
Show member pathways
8.7MAPK3, FOS, NTRK1
14
Show member pathways
Cytoskeleton remodeling FAK signaling60
Development Endothelin 1 EDNRA transactivation of EGFR60
8.7FOS, MAPK3, NTRK1
158.6MAPK3, GDNF, FOS
16
Show member pathways
8.5STAT3, MAPK3, FOS
178.5STAT3, MAPK3, FOS
188.5STAT3, FOS, MAPK3
19
Show member pathways
IL23-mediated signaling events38
Immune response IL 10 signaling pathway60
Angiopoietin receptor Tie2-mediated signaling38
Development PDGF signaling via STATs and NF kB60
Development Angiopoietin Tie2 signaling60
8.5MAPK3, FOS, STAT3
20
Show member pathways
8.5MAPK3, FOS, STAT3
21
Show member pathways
Signal transduction PTEN pathway60
8.5FOS, STAT3, MAPK3
228.5MAPK3, FOS, STAT3
23
Show member pathways
IL-9 Signaling Pathway38
Development Thrombopoietin regulated cell processes60
IL-7 Signaling Pathway38
Immune response IL 9 signaling pathway60
8.5FOS, MAPK3, STAT3
24
Show member pathways
8.5MAPK3, FOS, STAT3
258.5FOS, STAT3, MAPK3
26
Show member pathways
8.5STAT3, FOS, MAPK3
27
Show member pathways
Immune response BCR pathway60
Fc-epsilon receptor I signaling in mast cells38
8.5STAT3, FOS, MAPK3
28
Show member pathways
IL-2 Signaling pathway38
8.5FOS, MAPK3, STAT3
29
Show member pathways
Prolactin Signaling Pathway38
Development Prolactin receptor signaling60
Leptin signaling pathway38
8.5FOS, STAT3, MAPK3
30
Show member pathways
Immune response IL 22 signaling pathway60
G protein signaling N RAS regulation pathway60
8.5STAT3, FOS, MAPK3
318.5MAPK3, FOS, STAT3
328.5MAPK3, FOS, STAT3
33
Show member pathways
MAPK Cascade38
Immune response Oncostatin M signaling via MAPK in human cells60
Oncostatin M Signaling Pathway38
8.5FOS, STAT3, MAPK3
34
Show member pathways
ErbB receptor signaling network38
ErbB signaling pathway38
8.5MAPK3, FOS, STAT3
35
Show member pathways
8.5FOS, MAPK3, STAT3
36
Show member pathways
8.5MAPK3, STAT3, FOS
37
Show member pathways
8.5MAPK3, STAT3, FOS
388.5MAPK3, STAT3, FOS
39
Show member pathways
Prostate Cancer38
Integrated Cancer pathway38
Steroid Biosynthesis38
8.5MAPK3, STAT3, FOS
40
Show member pathways
8.5MAPK3, STAT3, FOS
41
Show member pathways
Alzheimers Disease38
8.5SDHC, SDHB, SDHD, MAPK3
42
Show member pathways
8.2STAT3, FOS, NTRK1, MAPK3
43
Show member pathways
8.2MAPK3, NTRK1, FOS, STAT3
44
Show member pathways
8.2FOS, STAT3, NTRK1, MAPK3
45
Show member pathways
Development EGFR signaling via PIP360
Development PDGF signaling via MAPK cascades60
Apoptosis and survival Anti apoptotic action of membrane bound ESR160
Signaling of Hepatocyte Growth Factor Receptor38
Development EGFR signaling via small GTPases60
Development Neurotrophin family signaling60
Apoptosis and survival NGF signaling pathway60
Apoptosis and survival Role of CDK5 in neuronal death and survival60
8.2MAPK3, NTRK1, FOS, STAT3
468.2MAPK3, STAT3, NTRK1, FOS
47
Show member pathways
8.2NTRK1, MAPK3, STAT3, FOS
487.9FOS, MAPK3, RET, NTRK1, STAT3
49
Show member pathways
7.8STAT3, MAPK3, NTRK1, FOS, GDNF
50
Show member pathways
Development ERBB family signaling60
Development GDNF family signaling60
7.8FOS, STAT3, GDNF, RET, MAPK3

Compounds for genes affiliated with Familial Medullary Thyroid Carcinoma

About this section
Sources:
45Novoseek, 24HMDB, 11DrugBank, 29IUPHAR, 51PharmGKB, 61Tocris Bioscience, 3BitterDB
See all sources

Compounds related to Familial Medullary Thyroid Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 99)
idCompoundScoreTop Affiliating Genes
1cipa4510.2NTRK1, RET
2mibg459.7SDHB, SDHD, CALCA
3Fumaric acid249.6SDHB, SDHC, SDHD
4fumarate45 1110.5SDHB, SDHD, SDHC
5succinic acid29 24 1111.5SDHB, SDHC, SDHD
6iron-sulfur459.5SDHC, SDHD, SDHB
7ubiquinone459.5SDHC, SDHD, SDHB
8Sulfide249.4SDHD, SDHB, SDHC
9QH2249.4SDHC, SDHB, SDHD
10Ubiquinone Q2249.4SDHD, SDHC, SDHB
11Ubiquinone Q1249.3SDHD, SDHC, SDHB
12succinate459.2SDHD, RET, SDHC, SDHB
13vanadate459.1MAPK3, STAT3, NTRK1
14catecholamine459.1GDNF, SDHB, SDHD, RET, NTRK1
15capsaicin45 2910.0CALCA, NTRK1, FOS, GDNF
16norepinephrine45 24 1110.8CALCA, MAPK3, SDHB, GDNF
17butyrate458.7MAPK3, RET, FOS, NTRK1
18iron45 249.6STAT3, SDHC, SDHD, SDHB, GDNF
19agar458.5RET, MAPK3, STAT3, FOS
20ag 1478458.5STAT3, MAPK3, FOS
21tamoxifen45 51 29 1111.4MAPK3, FOS, STAT3, NTRK1
22oxygen45 249.4SDHB, GDNF, NTRK1, SDHC, SDHD
23losartan45 51 29 1111.4MAPK3, FOS, STAT3
24oligonucleotide458.4NTRK1, STAT3, FOS, RET, GDNF
25nmda45 299.4GDNF, MAPK3, SDHB, FOS
26testosterone45 61 24 1111.3CALCA, MAPK3, NTRK1, RET, STAT3, SDHB
27phosphotyrosine458.3MAPK3, NTRK1, FOS, STAT3, RET
2812-o-tetradecanoylphorbol 13-acetate458.3NTRK1, FOS, STAT3, RET, MAPK3
29aspartate458.3RET, SDHB, STAT3, MAPK3, GDNF, NTRK1
30alanine458.2NTRK1, MAPK3, GDNF, SDHB, RET, STAT3
31anisomycin45 119.2FOS, STAT3, MAPK3
32atp45 299.2MAPK3, RET, GDNF, NTRK1, SDHB, STAT3
33cysteine458.2GDNF, SDHB, NTRK1, STAT3, RET, MAPK3
34phosphoinositide458.2MAPK3, NTRK1, FOS, STAT3, GDNF
35cyclic amp45 249.1FOS, RET, NTRK1, MAPK3, CALCA, GDNF
36threonine458.1MAPK3, RET, NTRK1, STAT3, FOS
37pd 98,059457.9GDNF, MAPK3, NTRK1, RET, FOS, STAT3
38ly294002457.9FOS, RET, STAT3, NTRK1, MAPK3, GDNF
39wortmannin457.9MAPK3, NTRK1, FOS, STAT3, GDNF, RET
40glutamate457.9SDHB, FOS, MAPK3, CALCA, NTRK1, GDNF
41genistein45 29 61 3 24 1112.9GDNF, MAPK3, RET, FOS, NTRK1, STAT3
42phosphatidylinositol457.9GDNF, RET, MAPK3, NTRK1, FOS, STAT3
43estrogen457.8CALCA, MAPK3, STAT3, FOS, NTRK1, GDNF
44h2o2457.8GDNF, SDHB, FOS, NTRK1, MAPK3, STAT3
45dopamine45 29 24 1110.6GDNF, SDHB, RET, MAPK3, CALCA, FOS
46serine457.6FOS, RET, NTRK1, MAPK3, GDNF, STAT3
47calcium45 51 24 1110.5GDNF, RET, SDHB, FOS, NTRK1, MAPK3
48tyrosine457.4MAPK3, GDNF, FOS, STAT3, RET, SDHB
49retinoic acid45 248.4RET, SDHC, NTRK1, GDNF, FOS, STAT3
50vegf456.6CALCA, GDNF, SDHB, SDHC, RET, STAT3

GO Terms for genes affiliated with Familial Medullary Thyroid Carcinoma

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Familial Medullary Thyroid Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial inner membraneGO:0057439.1SDHC, SDHD, SDHB
2mitochondrial respiratory chain complex IIGO:0057498.8SDHC, SDHD, SDHB

Biological processes related to Familial Medullary Thyroid Carcinoma according to GeneCards/GeneDecks:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1detection of temperature stimulus involved in sensory perception of painGO:05096510.2NTRK1, CALCA
2response to painGO:04826510.1RET, CALCA
3enteric nervous system developmentGO:04848410.0RET, GDNF
4sympathetic nervous system developmentGO:04848510.0GDNF, NTRK1
5activation of adenylate cyclase activityGO:00719010.0CALCA, NTRK1
6neural crest cell migrationGO:0017559.8RET, GDNF
7aerobic respirationGO:0090609.8SDHC, SDHB
8JAK-STAT cascade involved in growth hormone signaling pathwayGO:0603979.6MAPK3, STAT3
9phosphorylationGO:0163109.6STAT3, MAPK3
10tricarboxylic acid cycleGO:0060999.5SDHC, SDHD, SDHB
11respiratory electron transport chainGO:0229049.5SDHC, SDHD, SDHB
12cellular metabolic processGO:0442379.4SDHC, SDHD, SDHB
13cellular response to hormone stimulusGO:0328709.3FOS, STAT3
14agingGO:0075689.3CALCA, NTRK1, FOS
15activation of MAPKK activityGO:0001869.3MAPK3, NTRK1
16protein phosphorylationGO:0064689.2RET, NTRK1, MAPK3, CALCA
17neurotrophin TRK receptor signaling pathwayGO:0480119.2STAT3, NTRK1, MAPK3
18axon guidanceGO:0074119.0MAPK3, NTRK1, GDNF
19regulation of sequence-specific DNA binding transcription factor activityGO:0510909.0FOS, MAPK3
20stress-activated MAPK cascadeGO:0514039.0MAPK3, FOS
21response to drugGO:0424938.9NTRK1, FOS, STAT3, RET
22nervous system developmentGO:0073998.8FOS, STAT3, GDNF
23positive regulation of transcription from RNA polymerase II promoterGO:0459448.3MAPK3, FOS, STAT3, GDNF

Molecular functions related to Familial Medullary Thyroid Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1transmembrane receptor protein tyrosine kinase activityGO:0047149.9NTRK1, RET
2succinate dehydrogenase activityGO:0001049.6SDHC, SDHD
3ubiquinone bindingGO:0480399.5SDHD, SDHB
4electron carrier activityGO:0090558.8SDHC, SDHD, SDHB

Products for genes affiliated with Familial Medullary Thyroid Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Familial Medullary Thyroid Carcinoma

About this section
4CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
59SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet